An emerging anti-HIV-Pol mutant-specific CTL response responsible for selection of the consensus B like sequence in patient OP428.

AEstimated weeks from infection. BThe consensus B sequence spanning amino acid 28 to 46 in RT is given as a reference with the epitope RT 33-41 given in bold face letters. CThe frequency of each clone is given as a number of the total number of clones sequenced. The major autologous sequence at each time-point is indicated in bold face numbers. DThe autologous CTL responses are given for each peptide tested. The viral variant that generates the strongest CTL response at each time-point are given in bold.